Class 5. Pulmonary Hypertension Associated with Hematological, Systemic, Metabolic and Other Disorders

Low global arginine bioavailability: a common phenomenon in pulmonary hypertension

Dunia Hatabah, Teresa De Marco, Dana P. McGlothlin, Mary Malloy, Loretta Z. Reyes, Rawan Korman, Gregory J. Kato, Claudia R. MorrisEmory University School of Medicine. University of California, San Francisco. Kaiser Permanente San Francisco. Children’s Healthcare of Atlanta. Blood Science Consulting.United States American Journal of Physiology Lung Cellular and Molecular PhysiologyAm J Physiol Lung Cell […]

Low global arginine bioavailability: a common phenomenon in pulmonary hypertension Read More »

Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity

Mona Hamdy, Iman A. Shaheen, Mohamed Khallaf, Yasmeen M. M. SelimCairo University.Egypt Pediatric Blood and CancerPediatr Blood Cancer 2024; 71:DOI: 10.1002/pbc.30959 AbstractBackground: Thrombin is a critical protease modulating thrombosis as well as inflammation, which are one of the main pathophysiological mechanisms in sickle vasculopathy, and its levels were reported to be high in sickle cell disease (SCD).

Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity Read More »

Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry

Franklin Njoku, Norma Pugh, Donald Brambilla, Barbara Kroner, Nirmish Shah, Marsha Treadwell, Robert Gibson, Lewis L. Hsu, Victor R. Gordeuk, Jeffrey Glassberg, Jane S. Hankins, Abdullah Kutlar, Allison A. King, Julie KanterUniversity of Illinois at Chicago. Research Triangle International. Duke University. University of California San Francisco. Augusta University. Icahn School of Medicine at Mount Sinai.

Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry Read More »

Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment

Maria Chalia, Emilie Seager, Anupama Rao, Simon HannamGreat Ormond Street Hospital for Children.United Kingdom Acta PaediatricaActa Paediatr 2024; DOI: 10.1111/apa.17142 AbstractAim: Five to thirty percent of neonates with trisomy 21 develop transient abnormal myelopoiesis (TAM) with a high mortality rate. The aim of the study was to identify contributing factors that determine mortality and need for chemotherapy

Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment Read More »

[Clinical and genetic analysis of a patient with HUPRA syndrome due to missense variants of SARS2 gene and literature review]

J. Huang, Q. Y. Li. W. Ji, X.F. Guo, X. H. HuFujian Children’s Hospital. Beijing Anzhen Hospital and Capital Medical University. Shanghai Jiaotong University School of Medicine and Shanghai Children’s Medical Center. Fujian Provincial Maternity and Children’s Hospital. Xinhua Hospital.China Zhonghua Xin Xue Guan Bing Za Zhi 2024; 52: 172-179DOI: 10.3760/cma.j.cn112148-20231009-00268 Abstract (English)Objective: To explore the clinical

[Clinical and genetic analysis of a patient with HUPRA syndrome due to missense variants of SARS2 gene and literature review] Read More »

Variants in the SARS2 gene cause HUPRA syndrome with atypical features: two case reports and review of the literature

Elias Edward Lahham, JuhinaJamal Hasassneh, Dua Osamah Adawi, Mohamad Khaled IsmailAugusta Victoria Hospital. Beit-Jala Governmental Hospital.Palestine Oxford Medical Case ReportsOxford Med Case Rep 2023; 11: 407–409DOI: 10.1093/omcr/omad119 AbstractHyperuricemia, pulmonary hypertension, renal failure in infancy, and alkalosis (HUPRA syndrome) is a rare autosomal recessive mitochondrial disease with a prevalence of <1:1 000 000, due to variations in

Variants in the SARS2 gene cause HUPRA syndrome with atypical features: two case reports and review of the literature Read More »

Pulmonary Artery Hypertension in Transfusion-Dependent Thalassemia

Vineeta Gupta, Vishnu Vijayakumar, Priyanka Aggarwal Ishan Kumar, Vikas AgrawalBanaras Hindu University. India Indian PediatricsIndian Pediatr 2024; 61: 49-52DOI: Not Available AbstractObjective: Patients with transfusion-dependent thalassemia (TDT) are at risk of developing pulmonary artery hypertension (PAH) due to chronic hemolysis, iron overload, hypercoagulability and splenectomy. The objective of the study was to assess the prevalence and

Pulmonary Artery Hypertension in Transfusion-Dependent Thalassemia Read More »

Reversible severe pulmonary hypertension related to scurvy in children

Marin Satawiriya, Apichai Khongphatthanayothin, Alisa LimsuwanFaculty of Medicine Ramathibodi Hospital and Mahidol University. Bangkok Heart Hospital. Chulalongkorn University. Thailand BioMed Central Cardiovascular DisordersBMC Cardiovasc Disord 2024; 24:DOI: 10.1186/s12872-023-03629-6 AbstractBackground: Severe pulmonary hypertension (PH) in childhood is rare and can manifest as a life-threatening episode. We present 2 children with restrictive dietary habits with severe pulmonary hypertension secondary

Reversible severe pulmonary hypertension related to scurvy in children Read More »

Sickle Cell Disease

MA Bender, Katie CarlbergUniversity of Washington.United States GeneReviews (Internet)GeneReviews 2023;DOI: Not Available. Bookshelf ID: NBK1377 AbstractExcerptClinical characteristics: Sickle cell disease (SCD) is characterized by intermittent vaso-occlusive events and chronic hemolytic anemia. Vaso-occlusive events result in tissue ischemia leading to acute and chronic pain as well as organ damage that can affect any organ system, including the bones, spleen,

Sickle Cell Disease Read More »

Cardiovascular complications of sickle cell disease: A primer for the general clinician

Chibuzo Ilonze, Gift C. Echefu, Alexandria L. Broadnax, Adedoyin Johnson, Aniekeme Etuk, Onyedika J. IlonzeUniversity of Alabama at Birmingham. University of Tennessee Health Science Center. Indiana University School of Medicine. Infirmary Health Thomas Hospital.United States Journal of the National Medical AssociationJ Natl Med Assoc 2023;DOI: 10.1016/j.jnma.2023.11.010 AbstractSickle cell disease (SCD) is the most common hereditary hemoglobinopathy

Cardiovascular complications of sickle cell disease: A primer for the general clinician Read More »

Scroll to Top